可乐必妥（Levofloxacin）治疗肺结核的临床研究

可乐必妥（Levofloxacin）治疗肺结核的临床研究

目的评价左氧氟沙星治疗肺结核的疗效、适宜剂量和在我国应用的前景。方法９７年初治菌阳肺结核随机分为治疗组（２ＨＬ２Ｖ／４ＨＬ２、５０例）和对照组（２ＨＬ２Ｚ／４ＨＬ２、４７例）进行短程化疗。结果治疗组和对照组２个月痰菌阴转率分别为９４．０％和８３．０％；满疗程痰菌阴转率分别为９８．０％和９７．９％。胸部Ｘ线所见，治疗组和对照组病灶吸收分别为９８．０％和９５．７％，两组分别有７３．１％和５０．０...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Zhongguo fanglao tongxun 2000, Vol.22 (2), p.63-65
1. Verfasser:	马丽萍王庆枫
Format:	Artikel
Sprache:	chi
Schlagworte:	左氧氟沙星肺结核药物疗法
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	65
container_issue	2
container_start_page	63
container_title	Zhongguo fanglao tongxun
container_volume	22
creator	马丽萍王庆枫
description	目的评价左氧氟沙星治疗肺结核的疗效、适宜剂量和在我国应用的前景。方法９７年初治菌阳肺结核随机分为治疗组（２ＨＬ２Ｖ／４ＨＬ２、５０例）和对照组（２ＨＬ２Ｚ／４ＨＬ２、４７例）进行短程化疗。结果治疗组和对照组２个月痰菌阴转率分别为９４．０％和８３．０％；满疗程痰菌阴转率分别为９８．０％和９７．９％。胸部Ｘ线所见，治疗组和对照组病灶吸收分别为９８．０％和９５．７％，两组分别有７３．１％和５０．０
format	Article
fullrecord	<record><control><sourceid>chongqing</sourceid><recordid>TN_cdi_chongqing_backfile_4432530</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>4432530</cqvip_id><sourcerecordid>4432530</sourcerecordid><originalsourceid>FETCH-chongqing_backfile_44325303</originalsourceid><addsrcrecordid>eNpjYeA0NDAw0DUzMzLkYOAtLs5MMjAwNjQ1MjA05GSwedq__snOCU_3tz5dtvT9ng6f1LL8tJz8isTkzLz3ezqfbdr9fNr0F027nu-e_GzBjuezWp7s2PJ0V9fzBVOer9zGw8CalphTnMoLpbkZFN1cQ5w9dJMz8vPSCzPz0uOTEpOz0zJzUuNNTIyNTI0NjIlRAwBLlUez</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>可乐必妥（Levofloxacin）治疗肺结核的临床研究</title><source>Alma/SFX Local Collection</source><creator>马丽萍王庆枫</creator><creatorcontrib>马丽萍王庆枫</creatorcontrib><description>目的评价左氧氟沙星治疗肺结核的疗效、适宜剂量和在我国应用的前景。方法９７年初治菌阳肺结核随机分为治疗组（２ＨＬ２Ｖ／４ＨＬ２、５０例）和对照组（２ＨＬ２Ｚ／４ＨＬ２、４７例）进行短程化疗。结果治疗组和对照组２个月痰菌阴转率分别为９４．０％和８３．０％；满疗程痰菌阴转率分别为９８．０％和９７．９％。胸部Ｘ线所见，治疗组和对照组病灶吸收分别为９８．０％和９５．７％，两组分别有７３．１％和５０．０</description><identifier>ISSN: 1000-6621</identifier><language>chi</language><subject>左氧氟沙星 ; 肺结核 ; 药物疗法</subject><ispartof>Zhongguo fanglao tongxun, 2000, Vol.22 (2), p.63-65</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/90169A/90169A.jpg</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids></links><search><creatorcontrib>马丽萍王庆枫</creatorcontrib><title>可乐必妥（Levofloxacin）治疗肺结核的临床研究</title><title>Zhongguo fanglao tongxun</title><addtitle>The Journal of The Chinese Antituberculosis Association</addtitle><description>目的评价左氧氟沙星治疗肺结核的疗效、适宜剂量和在我国应用的前景。方法９７年初治菌阳肺结核随机分为治疗组（２ＨＬ２Ｖ／４ＨＬ２、５０例）和对照组（２ＨＬ２Ｚ／４ＨＬ２、４７例）进行短程化疗。结果治疗组和对照组２个月痰菌阴转率分别为９４．０％和８３．０％；满疗程痰菌阴转率分别为９８．０％和９７．９％。胸部Ｘ线所见，治疗组和对照组病灶吸收分别为９８．０％和９５．７％，两组分别有７３．１％和５０．０</description><subject>左氧氟沙星</subject><subject>肺结核</subject><subject>药物疗法</subject><issn>1000-6621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpjYeA0NDAw0DUzMzLkYOAtLs5MMjAwNjQ1MjA05GSwedq__snOCU_3tz5dtvT9ng6f1LL8tJz8isTkzLz3ezqfbdr9fNr0F027nu-e_GzBjuezWp7s2PJ0V9fzBVOer9zGw8CalphTnMoLpbkZFN1cQ5w9dJMz8vPSCzPz0uOTEpOz0zJzUuNNTIyNTI0NjIlRAwBLlUez</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>马丽萍王庆枫</creator><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope></search><sort><creationdate>2000</creationdate><title>可乐必妥（Levofloxacin）治疗肺结核的临床研究</title><author>马丽萍王庆枫</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-chongqing_backfile_44325303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2000</creationdate><topic>左氧氟沙星</topic><topic>肺结核</topic><topic>药物疗法</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>马丽萍王庆枫</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><jtitle>Zhongguo fanglao tongxun</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>马丽萍王庆枫</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>可乐必妥（Levofloxacin）治疗肺结核的临床研究</atitle><jtitle>Zhongguo fanglao tongxun</jtitle><addtitle>The Journal of The Chinese Antituberculosis Association</addtitle><date>2000</date><risdate>2000</risdate><volume>22</volume><issue>2</issue><spage>63</spage><epage>65</epage><pages>63-65</pages><issn>1000-6621</issn><abstract>目的评价左氧氟沙星治疗肺结核的疗效、适宜剂量和在我国应用的前景。方法９７年初治菌阳肺结核随机分为治疗组（２ＨＬ２Ｖ／４ＨＬ２、５０例）和对照组（２ＨＬ２Ｚ／４ＨＬ２、４７例）进行短程化疗。结果治疗组和对照组２个月痰菌阴转率分别为９４．０％和８３．０％；满疗程痰菌阴转率分别为９８．０％和９７．９％。胸部Ｘ线所见，治疗组和对照组病灶吸收分别为９８．０％和９５．７％，两组分别有７３．１％和５０．０</abstract></addata></record>
fulltext	fulltext
identifier	ISSN: 1000-6621
ispartof	Zhongguo fanglao tongxun, 2000, Vol.22 (2), p.63-65
issn	1000-6621
language	chi
recordid	cdi_chongqing_backfile_4432530
source	Alma/SFX Local Collection
subjects	左氧氟沙星肺结核药物疗法
title	可乐必妥（Levofloxacin）治疗肺结核的临床研究
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A48%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-chongqing&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E5%8F%AF%E4%B9%90%E5%BF%85%E5%A6%A5%EF%BC%88Levofloxacin%EF%BC%89%E6%B2%BB%E7%96%97%E8%82%BA%E7%BB%93%E6%A0%B8%E7%9A%84%E4%B8%B4%E5%BA%8A%E7%A0%94%E7%A9%B6&rft.jtitle=Zhongguo%20fanglao%20tongxun&rft.au=%E9%A9%AC%E4%B8%BD%E8%90%8D%20%E7%8E%8B%E5%BA%86%E6%9E%AB&rft.date=2000&rft.volume=22&rft.issue=2&rft.spage=63&rft.epage=65&rft.pages=63-65&rft.issn=1000-6621&rft_id=info:doi/&rft_dat=%3Cchongqing%3E4432530%3C/chongqing%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_cqvip_id=4432530&rfr_iscdi=true